James R. Anderson

Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD

George P. Canellos, James R. Anderson, Kathleen J. Propert et al. · New England Journal of Medicine · 1992 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +14

Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease

William M. Crist, James R. Anderson, Jane L. Meza et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Medicine, Oncology, Surgery +16

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

Georgina V. Long, Reinhard Dummer, Omid Hamid et al. · The Lancet Oncology · 2019 · 944 citations

Medicine, Oncology, Pharmacotherapy +15

Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors

Jack F. Shern, Li Chen, Juliann Chmielecki et al. · Cancer Discovery · 2014 · 777 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma

Caroline Robert, Antoni Ribas, Omid Hamid et al. · Journal of Clinical Oncology · 2017 · 482 citations · Full text

Medicine, Oncology, Pharmacotherapy +17